study of open-access publishingpublished last week in the open-access journal PLoS ONE -has found that the number of papers in freely accessible journals is growing at a steady 20% per year (M. Laakso et al. PLoS ONE 6, e20961; 2011) . To many, the growth confirms the health of the free-access, author-pays model. But to a few it is a discouraging sign that open access is not about to take over the world of scholarly publishing.
The Larson et al. Lancet doi:10.1016/S0140-6736(11)60678-8; 2011) . Because most of the vaccines now in development are aimed at diseases common in the developing world, such as malaria, tuberculosis, leishmaniasis and helminth infections, antivaccination movements in such countries could have a major impact on public health, adds Richard Moxon, a paediatrician at the John Radcliffe Hospital in Oxford, UK.
Jacob Puliyel, head of paediatrics at St Stephen's Hospital in Delhi, has been a vocal opponent of both the HPV vaccines and the pentavalent vaccine. He does not endorse the vaccine fears that gripped the public after the four girls' deaths, but he told Nature that too little is known about the prevalence of Hib and HPV-related cervical cancer in India to justify the new vaccines. At a time when India is already struggling to achieve universal coverage with existing vaccines -coverage for basic childhood immunizations is just 63%, according to Khera -the country simply cannot afford them, Puliyel says. ■ The number of open-access articles and journals has been steadily increasing since 2000.
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Open access comes of age
Publishing model enters phase of slower but steady growth.
